Article, 2024

Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data

VACCINE, ISSN 0264-410X, Volume 42, 5, Pages 1094-1107, 10.1016/j.vaccine.2024.01.037

Contributors

Dreyfus, Jill (Corresponding author) [1] Munnangi, Swapna [2] Bengtsson, Camilla [3] Correia, Barbara [4] Figueiredo, Rejane [5] Stark, J. H. 0000-0002-0728-876X [6] Zawora, Michele [1] Riddle, Mark [1] Maguire, Jason D. [1] Jiang, Qin [1] Ianos, Claudia [7] Turrado, Juan Naredo [8] Svanstrom, Henrik [9] Bailey, Steven [1] DeKoven, Mitchell [2]

Affiliations

  1. [1] Pfizer Inc, New York, NY 10001 USA
    2. [NORA names: United States; America, North; OECD];
  2. [2] IQVIA, Falls Church, VA USA
    3. [NORA names: United States; America, North; OECD];
  3. [3] IQVIA, Solna, Sweden
    4. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  4. [4] IQVIA, Oeiras, Portugal
    5. [NORA names: Portugal; Europe, EU; OECD];
  5. [5] IQVIA, Espoo, Finland
    6. [NORA names: Finland; Europe, EU; Nordic; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

Background incidence rates, Epidemiology, Lyme disease, Vaccine

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+